These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 19196394)

  • 21. RUNX3 inhibits survivin expression and induces cell apoptosis in gastric cancer.
    Liu Z; Zhang X; Xu X; Chen L; Li W; Yu H; Sun Y; Zeng J; Jia J
    Eur J Cell Biol; 2014 Mar; 93(3):118-26. PubMed ID: 24636883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-tumor chemotherapy utilizing peptide-based approaches--apoptotic pathways, kinases, and proteasome as targets.
    Mendoza FJ; Espino PS; Cann KL; Bristow N; McCrea K; Los M
    Arch Immunol Ther Exp (Warsz); 2005; 53(1):47-60. PubMed ID: 15761376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multitargeted inhibitors in lung cancer: new clinical data.
    Bar J; Herbst RS; Onn A
    Clin Lung Cancer; 2008; 9 Suppl 3():S92-9. PubMed ID: 19419930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of new anti-cancer agents.
    Lobbezoo MW; Krul MR; Pinedo HM
    Forum (Genova); 1999; 9(3 Suppl 3):47-53. PubMed ID: 10607846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activated CD4+ T cells dramatically enhance chemotherapeutic tumor responses in vitro and in vivo.
    Radfar S; Wang Y; Khong HT
    J Immunol; 2009 Nov; 183(10):6800-7. PubMed ID: 19846868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
    Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
    Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antitumour and immune-adjuvant activities of protein-tyrosine kinase inhibitors.
    Seliger B; Massa C; Rini B; Ko J; Finke J
    Trends Mol Med; 2010 Apr; 16(4):184-92. PubMed ID: 20304705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular genetics and mechanisms of apoptosis in carcinomas of the lung and pleura: therapeutic targets.
    Motadi LR; Misso NL; Dlamini Z; Bhoola KD
    Int Immunopharmacol; 2007 Dec; 7(14):1934-47. PubMed ID: 18039530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel targets in gastric and esophageal cancer.
    Valverde CM; Macarulla T; Casado E; Ramos FJ; Martinelli E; Tabernero J
    Crit Rev Oncol Hematol; 2006 Aug; 59(2):128-38. PubMed ID: 16829119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transglutaminase 2: a multi-tasking protein in the complex circuitry of inflammation and cancer.
    Mehta K; Kumar A; Kim HI
    Biochem Pharmacol; 2010 Dec; 80(12):1921-9. PubMed ID: 20599779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oncogenic role of RUNX3 in head and neck cancer.
    Kudo Y; Tsunematsu T; Takata T
    J Cell Biochem; 2011 Feb; 112(2):387-93. PubMed ID: 21268058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Anti-tumor effect of eukaryotic expressing plasmid containing soluble tumor necrotic factor-related apoptosis inducing ligand combined with human angiostatin Kringle (1 - 3) genes on human gastric cancer xenografts in nude mice].
    Sun W; Jiang Z; Xiang TX; Tao XH; Huang AL; Wang PL
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(12):841-5. PubMed ID: 19595126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene deregulation in gastric cancer.
    Stock M; Otto F
    Gene; 2005 Oct; 360(1):1-19. PubMed ID: 16154715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted therapies in the treatment of gastric cancer.
    Ngeow J; Tan IB; Choo SP
    Asia Pac J Clin Oncol; 2011 Sep; 7(3):224-35. PubMed ID: 21884434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Constitutive NF-kappaB activation in colorectal carcinoma plays a key role in angiogenesis, promoting tumor growth.
    Sakamoto K; Maeda S; Hikiba Y; Nakagawa H; Hayakawa Y; Shibata W; Yanai A; Ogura K; Omata M
    Clin Cancer Res; 2009 Apr; 15(7):2248-58. PubMed ID: 19276252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of non-small cell lung cancer cell proliferation and tumor growth by vector-based small interfering RNAs targeting HER2/neu.
    Ren XL; Xu YM; Bao W; Fu HJ; Wu CG; Zhao Y; Li ZK; Zhang J; Li SQ; Chen WQ; Wang T; Zhang R; Zhang LH; Qian GS; Chen SY; Jia LT; Yang AG
    Cancer Lett; 2009 Aug; 281(2):134-43. PubMed ID: 19339104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transgenic cyclooxygenase-2 expression and high salt enhanced susceptibility to chemical-induced gastric cancer development in mice.
    Leung WK; Wu KC; Wong CY; Cheng AS; Ching AK; Chan AW; Chong WW; Go MY; Yu J; To KF; Wang X; Chui YL; Fan DM; Sung JJ
    Carcinogenesis; 2008 Aug; 29(8):1648-54. PubMed ID: 18611916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancement of doxorubicin cytotoxicity on human esophageal squamous cell carcinoma cells by indomethacin and 4-[5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC236) via inhibiting P-glycoprotein activity.
    Yu L; Wu WK; Li ZJ; Liu QC; Li HT; Wu YC; Cho CH
    Mol Pharmacol; 2009 Jun; 75(6):1364-73. PubMed ID: 19264847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
    Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
    Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
    Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
    Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.